Zealand Pharma A/S Tangible Net Worth Ratio
Zealand Pharma A/S tangible net worth ratio. Zealand Pharma A/S (ZEAL) has a Tangible Net Worth Ratio of 99.7% as of December 2025. This metric is calculated by deducting intangible assets (Dkr44.97 Million) from net assets (Dkr14.83 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check ZEAL strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Zealand Pharma A/S (2007–2025)
Tangible net worth ratio of Zealand Pharma A/S from 2007 to 2025. This chart shows how Zealand Pharma A/S's Tangible Net Worth Ratio has changed across 19 annual periods from 2007 to 2025. As of December 2025, the ratio stands at 99.7%, reflecting net assets of Dkr14.83 Billion with intangible assets of Dkr44.97 Million DKK. See working capital position of Zealand Pharma A/S to evaluate short-term liquidity relative to the company's equity base.
Zealand Pharma A/S Tangible Net Worth Ratio by Year (2007–2025)
Zealand Pharma A/S tangible net worth ratio by year from 2007 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Zealand Pharma A/S from 2007 to 2025, covering 19 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see ZEAL stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (DKK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.7% | Dkr14.83 Billion | Dkr44.97 Million | Dkr16.46 Billion | ▼ -0.2 pp |
| 2024 | 99.9% | Dkr8.62 Billion | Dkr12.62 Million | Dkr9.51 Billion | ▲ +0.6 pp |
| 2023 | 99.2% | Dkr1.59 Billion | Dkr12.26 Million | Dkr1.98 Billion | ▼ -0.8 pp |
| 2022 | 100.0% | Dkr815.91 Million | Dkr0.00 | Dkr1.54 Billion | ▲ +5.8 pp |
| 2021 | 94.2% | Dkr927.80 Million | Dkr53.79 Million | Dkr2.07 Billion | ▼ -0.9 pp |
| 2020 | 95.1% | Dkr1.18 Billion | Dkr57.48 Million | Dkr1.92 Billion | ▼ -4.7 pp |
| 2019 | 99.8% | Dkr1.24 Billion | Dkr2.48 Million | Dkr1.60 Billion | ▼ -0.2 pp |
| 2018 | 100.0% | Dkr1.12 Billion | Dkr0.00 | Dkr1.23 Billion | ▲ +0.0 pp |
| 2017 | 100.0% | Dkr528.47 Million | Dkr0.00 | Dkr737.24 Million | ▲ +0.0 pp |
| 2016 | 100.0% | Dkr278.19 Million | Dkr0.00 | Dkr694.63 Million | ▲ +0.0 pp |
| 2015 | 100.0% | Dkr252.23 Million | Dkr0.00 | Dkr634.69 Million | ▲ +0.0 pp |
| 2014 | 100.0% | Dkr252.83 Million | Dkr0.00 | Dkr596.76 Million | ▲ +0.0 pp |
| 2013 | 100.0% | Dkr316.14 Million | Dkr0.00 | Dkr346.91 Million | ▲ +0.0 pp |
| 2012 | 100.0% | Dkr491.01 Million | Dkr0.00 | Dkr522.40 Million | ▲ +0.0 pp |
| 2011 | 100.0% | Dkr441.40 Million | Dkr0.00 | Dkr469.48 Million | ▲ +0.0 pp |
| 2010 | 100.0% | Dkr407.11 Million | Dkr0.00 | Dkr450.55 Million | ▲ +0.0 pp |
| 2009 | 100.0% | Dkr132.92 Million | Dkr0.00 | Dkr158.68 Million | ▲ +0.0 pp |
| 2008 | 100.0% | Dkr208.63 Million | Dkr0.00 | Dkr225.24 Million | ▲ +0.0 pp |
| 2007 | 100.0% | Dkr242.37 Million | Dkr0.00 | Dkr263.37 Million | — |